Address	75/76 Wimpole Street London London & South East W1G 9RT United Kingdom
Employees	-
Website	http://akaritx.com
Updated	07/08/2019
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Coversin, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.